H-D-Pro-OMe*HCl

H-D-Pro-OMe*HCl is a stereochemically defined proline methyl ester hydrochloride, featuring a secondary cyclic amide (proline ring) with a chiral center at the α-position and a methyl ester at the carboxyl terminus. The hydrochloride salt form generates a protonated amine, improving handling and enabling controlled reactivity during peptide coupling and ester-based transformations. The ester functionality supports downstream conversion to amide and other activated derivatives, while the rigid pyrrolidine ring constrains conformational space relevant to proline-containing peptides and peptidomimetics. The compound's protected/derivatized amino acid format makes it suitable as a chiral amino acid intermediate for protected amino acid synthesis, peptide building block preparation, and stereoselective construction of nitrogen-containing scaffolds.

1. Peptide Synthesis

H-D-Pro-OMe*HCl is applied in peptide synthesis workflows where a proline methyl ester building block is required for C-terminal ester-to-amide conversion and subsequent coupling chemistry. The proline ring provides a conformationally constrained secondary amide nitrogen, while the α-chiral center and ester carbonyl enable stereochemically consistent incorporation into growing peptide chains. Salt formation with HCl supports reproducible handling of the amino component prior to N-protection or activation steps commonly used in protected amino acid synthesis. Downstream, the resulting proline-containing intermediates can be carried into peptide coupling strategies to generate peptides and peptide fragments used in biochemical research and process-scale fine chemical synthesis.

2. Protected Amino Acids

H-D-Pro-OMe*HCl serves as a chiral amino acid intermediate for producing N-protected proline derivatives and related protected amino acid building blocks. The methyl ester and protonated amine provide functional handles that can be orthogonally manipulated to match peptide synthesis protection-group logic, including conversion of the ester into activated carboxyl forms and subsequent N-protection strategies. The defined D-configuration supports stereochemical fidelity when preparing stereopure peptide components and chiral auxiliaries. The hydrochloride salt format can be leveraged in manufacturing routes to standardize feedstock handling for protected amino acid chemistry and controlled downstream derivatization.

3. Peptidomimetics And SAR Studies

H-D-Pro-OMe*HCl is suitable for peptidomimetic construction and structure-activity relationship studies where D-proline stereochemistry and rigid ring geometry influence backbone conformation. The cyclic proline structure and ester functionality enable rapid elaboration into amide-linked analogs, constrained scaffolds, and side-chain-modified fragments used for SAR exploration. Ester-to-amide transformations can be used to generate libraries of proline-containing analogs that probe how stereochemistry and conformational restriction affect binding motifs. The compound's amino acid derivative format also supports fragment-based molecular design and iterative medicinal chemistry intermediate preparation without disrupting the chiral center.

4. Chemical Biology And Protein Engineering

H-D-Pro-OMe*HCl can be employed in chemical biology research and protein engineering programs that require stereodefined proline-containing peptide segments for functional assays and structural studies. The amino acid backbone features a chiral α-center and a secondary amide within the pyrrolidine ring, supporting incorporation into peptide tags, binding motifs, and enzyme-interaction probes. Ester-derived intermediates can be converted into amide-linked constructs compatible with peptide-based conjugation and biomolecule modification workflows. The D-proline stereochemistry enables controlled variation of backbone stereochemical patterns used to interrogate recognition, stability, and conformational effects in protein and peptide systems.

5. Pharmaceutical Intermediate Preparation

H-D-Pro-OMe*HCl is relevant to pharmaceutical intermediate preparation where proline methyl ester derivatives act as chiral building blocks for constructing nitrogen-containing fragments and peptide-like intermediates. The hydrochloride salt and methyl ester allow feedstock standardization and can be integrated into process chemistry intermediate sequences that require controlled conversion of ester termini into activated carboxyl derivatives for amide formation. The rigid proline ring and defined stereochemistry support reproducible synthesis of stereopure intermediates used in fine chemical manufacturing and downstream API-related intermediate generation. The compound's amino acid derivative structure aligns with industrial planning for stereocontrolled synthesis of peptide analogs and proline-based scaffolds used in applied product development.

6. Analytical Standards And Method Development

H-D-Pro-OMe*HCl can be utilized as a stereochemically defined reference material for analytical method development targeting proline ester and proline-derived fragments. The D-configuration and ester hydrochloride form provide a distinct chemical identity that supports calibration, identity confirmation, and impurity profiling during amino acid derivatization and peptide building block preparation. The methyl ester and protonated amine enable formation of predictable derivatives under common analytical derivatization conditions, supporting chromatographic and mass spectrometric workflows. The compound thus functions as an amino acid-based intermediate standard that supports quality control and analytical research in peptide science and industrial chemical manufacturing.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats